Clinical Trial

Safety and Tolerability Trial of Psilocybin in Healthy Older Adults

Name: Safety and Tolerability Trial of Psilocybin in Healthy Older Adults — clinical trial record (NCT07516405)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: Psil-Pk

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This study plans to learn more about the safety and tolerability of psychedelic administration (psilocybin) in healthy older adults ages 65-85.

Protocol Amendment History 5 amendments

This ClinicalTrials.gov record has been amended 5 times since 2026-04-06; most recent amendment 2026-07-01.

Trial Details

NCT Number	NCT07516405
Lead Sponsor	University of Colorado, Denver Collaborators: National Institute on Aging (NIA), University of California, San Francisco, Emory University, Dana-Farber Cancer Institute, NYU Langone Health, University of Nebraska
Conditions	Healthy Volunteer, Older Adults (65-85 Years)
Enrollment	40 participants
Start Date	2026-04-01
Primary Completion	2028-03 (estimated)
Study Completion	2028-03 (estimated)
Updated on ClinicalTrials.gov	2026-08-10